You are here: Industry Insights > Antibiotic

News List

Nationalised drug firms may address superbug threat, says Jim O’Neill pharmaceutical-technology
April 11, 2019
Nationalised drug firms may address superbug threat, says Jim O’Neill.
Abbott's India centre takes its innovations global firstwordpharma
April 11, 2019
Abbott's India centre takes its innovations global.
Big pharma accused of no action on antibiotic threat europeanpharmaceuticalreview
April 02, 2019
The pharmaceutical industry needs to match words with action on researching new antibiotics to address the threat posed by drug-resistant superbugs…
Absorbable antibiotic envelope cuts cardiac infections europeanpharmaceuticalreview
March 19, 2019
An absorbable antibiotic envelope could cut the number of cardiac infections after surgery to implant or replace cardioverter defibrillators and pacemakers…
NICE assessments could reform in new superbug plan pharmaphorum
January 25, 2019
The UK government has published a new five year plan aimed at tackling antimicrobial resistance (AMR), including a new NHS reimbursement scheme backed by NICE to encourage pharma to develop new antibiotics.
UK unveils plan to tackle growing antimicrobial resistance pharmaceutical-technology
January 25, 2019
The UK Government has set out a plan to fight antimicrobial resistance (AMR) in the country by 2040, with an aim to cut down antibiotics use by 15% over the next five years....
Link between early antibiotic exposure and weight gain in young children europeanpharmaceuticalreview
November 05, 2018
A recent study has shown that antibiotics use in young children (under 24 months) could result in weight gain shown when the child reaches the age of 5…
Manchester team develops non-antibiotic drug against TB biospectrumasia
October 15, 2018
The team hopes that the compound developed after 10 years of painstaking research will be tried on humans within three to four years.
Antibiotic for skin condition granted Priority Review by FDA europeanpharmaceuticalreview
September 07, 2018
The US FDA have granted the NDA for iclaprim, an antibiotic for a skin condition, Priority Review, with a decision date set for February 2019…
US researchers find 8,000 new antibiotic combinations effective pharmaceutical-technology
September 06, 2018
Researchers at the University of California, Los Angeles (UCLA) have discovered that nearly 8,000 four and five-antibiotic combinations are more effective at treating their indicated conditions than previously thought.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page